 5. In the judgment of the investigator, any clinically significant finding of the medical examination including BP, PR and ECG or laboratory value deviating from normal or any evidence of a clinically significant concomitant disease or any other clinical condition that would jeopardize a patients safety while participating in the clinical trial 